Erasca to Present at Morgan Stanley Healthcare Conference

Event summary

Erasca to participate in Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026.
Management to engage in a fireside chat at 1:05 pm Eastern Time.
One-on-one investor meetings scheduled during the event.
Live audio webcast available on Erasca.com/events, replay accessible for 30 days.

The big picture

Erasca's participation in the Morgan Stanley Healthcare Conference underscores its focus on engaging with investors and showcasing its precision oncology pipeline. The event provides a platform for the company to highlight its strategic advancements in RAS/MAPK pathway-driven cancer therapies, amid a competitive landscape in oncology innovation. The scale of investor interest and the clarity of Erasca's clinical development roadmap will be key factors to observe.

What we're watching

Investor Sentiment: How Erasca's presentation will impact investor confidence in its RAS/MAPK pathway-driven cancer therapies.
Pipeline Updates: Whether Erasca will provide new insights into its clinical-stage pipeline during the conference.
Competitive Positioning: The pace at which Erasca can differentiate itself in the precision oncology space.